IL174950A0 - Amidomethyl-subsituted 2-(4-sulfonilamino)-3-hydroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds - Google Patents
Amidomethyl-subsituted 2-(4-sulfonilamino)-3-hydroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compoundsInfo
- Publication number
- IL174950A0 IL174950A0 IL174950A IL17495006A IL174950A0 IL 174950 A0 IL174950 A0 IL 174950A0 IL 174950 A IL174950 A IL 174950A IL 17495006 A IL17495006 A IL 17495006A IL 174950 A0 IL174950 A0 IL 174950A0
- Authority
- IL
- Israel
- Prior art keywords
- sulfonilamino
- amidomethyl
- subsituted
- dihydro
- chromium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10348298A DE10348298A1 (en) | 2003-10-17 | 2003-10-17 | Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation, and medicaments containing these compounds |
| PCT/EP2004/052539 WO2005037780A2 (en) | 2003-10-17 | 2004-10-14 | Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL174950A0 true IL174950A0 (en) | 2006-08-20 |
| IL174950A IL174950A (en) | 2010-06-30 |
Family
ID=34442032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL174950A IL174950A (en) | 2003-10-17 | 2006-04-11 | Amidomethyl-subsituted 2 - (4 - sulfonilamino) - 3 - hydroxy - 3, 4 - dihydro -2h - chromen - 6 - yl -derivatives and drugs containing said compounds |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1678130B1 (en) |
| JP (1) | JP4791968B2 (en) |
| KR (1) | KR20060129170A (en) |
| CN (1) | CN100532375C (en) |
| AR (1) | AR046106A1 (en) |
| AT (1) | ATE405547T1 (en) |
| AU (1) | AU2004281195B2 (en) |
| BR (1) | BRPI0415523A (en) |
| CA (1) | CA2542813C (en) |
| DE (3) | DE10348298A1 (en) |
| DK (1) | DK1678130T3 (en) |
| ES (1) | ES2313126T3 (en) |
| HK (1) | HK1096960A1 (en) |
| HR (1) | HRP20080602T3 (en) |
| IL (1) | IL174950A (en) |
| MX (1) | MXPA06003958A (en) |
| NO (1) | NO20062202L (en) |
| PL (1) | PL1678130T3 (en) |
| PT (1) | PT1678130E (en) |
| RU (1) | RU2355685C2 (en) |
| SI (1) | SI1678130T1 (en) |
| TW (1) | TWI321564B (en) |
| UA (1) | UA82907C2 (en) |
| WO (1) | WO2005037780A2 (en) |
| ZA (1) | ZA200602788B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1871758B1 (en) * | 2005-04-12 | 2010-08-25 | Abbott Products GmbH | Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| US7714150B2 (en) | 2005-04-12 | 2010-05-11 | Solvay Pharmaceuticals Gmbh | Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives |
| JP4943429B2 (en) * | 2005-07-22 | 2012-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Potassium channel inhibitor |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
| JP2015504923A (en) | 2012-01-27 | 2015-02-16 | ギリアード サイエンシーズ， インコーポレイテッド | Combination therapy using late sodium ion channel blockers and potassium ion channel blockers |
| WO2014134419A1 (en) | 2013-03-01 | 2014-09-04 | Gilead Sciences, Inc. | Use of ikach blockers for the treatment of cardiac diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ282172B6 (en) * | 1992-11-30 | 1997-05-14 | Smithkline Beecham Plc | Benzopyran analogs process for preparing such compounds, pharmaceutical composition containing such compounds and the use thereof |
| DE19546736A1 (en) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations |
| WO2000012077A1 (en) * | 1998-09-01 | 2000-03-09 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
| WO2000058300A1 (en) * | 1999-03-25 | 2000-10-05 | Nissan Chemical Industries, Ltd. | Chroman derivatives |
| JP2000336085A (en) * | 1999-03-25 | 2000-12-05 | Nissan Chem Ind Ltd | Chroman derivative |
| AU781365B2 (en) * | 1999-12-21 | 2005-05-19 | Icagen, Inc. | Potassium channel inhibitors |
-
2003
- 2003-10-17 DE DE10348298A patent/DE10348298A1/en not_active Withdrawn
-
2004
- 2004-10-13 AR ARP040103705A patent/AR046106A1/en not_active Application Discontinuation
- 2004-10-13 TW TW093130943A patent/TWI321564B/en not_active IP Right Cessation
- 2004-10-14 CN CNB2004800283503A patent/CN100532375C/en not_active Expired - Fee Related
- 2004-10-14 MX MXPA06003958A patent/MXPA06003958A/en active IP Right Grant
- 2004-10-14 PT PT04817204T patent/PT1678130E/en unknown
- 2004-10-14 RU RU2006116629/04A patent/RU2355685C2/en not_active IP Right Cessation
- 2004-10-14 DE DE112004001659T patent/DE112004001659D2/en not_active Expired - Fee Related
- 2004-10-14 DE DE502004007916T patent/DE502004007916D1/en active Active
- 2004-10-14 DK DK04817204T patent/DK1678130T3/en active
- 2004-10-14 UA UAA200605330A patent/UA82907C2/en unknown
- 2004-10-14 WO PCT/EP2004/052539 patent/WO2005037780A2/en active IP Right Grant
- 2004-10-14 AT AT04817204T patent/ATE405547T1/en active
- 2004-10-14 SI SI200430848T patent/SI1678130T1/en unknown
- 2004-10-14 PL PL04817204T patent/PL1678130T3/en unknown
- 2004-10-14 EP EP04817204A patent/EP1678130B1/en active Active
- 2004-10-14 ZA ZA200602788A patent/ZA200602788B/en unknown
- 2004-10-14 JP JP2006534762A patent/JP4791968B2/en not_active Expired - Fee Related
- 2004-10-14 AU AU2004281195A patent/AU2004281195B2/en not_active Ceased
- 2004-10-14 CA CA2542813A patent/CA2542813C/en not_active Expired - Fee Related
- 2004-10-14 KR KR1020067006939A patent/KR20060129170A/en not_active Application Discontinuation
- 2004-10-14 ES ES04817204T patent/ES2313126T3/en active Active
- 2004-10-14 BR BRPI0415523-8A patent/BRPI0415523A/en not_active IP Right Cessation
-
2006
- 2006-04-11 IL IL174950A patent/IL174950A/en not_active IP Right Cessation
- 2006-05-16 NO NO20062202A patent/NO20062202L/en not_active Application Discontinuation
-
2007
- 2007-02-23 HK HK07102051.5A patent/HK1096960A1/en not_active IP Right Cessation
-
2008
- 2008-11-20 HR HR20080602T patent/HRP20080602T3/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG27104A (en) | Pharmaceutical compounds | |
| IL174950A0 (en) | Amidomethyl-subsituted 2-(4-sulfonilamino)-3-hydroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds | |
| GB0315657D0 (en) | Pharmaceutical compounds | |
| GB0324886D0 (en) | Medicinal compounds | |
| GB0217225D0 (en) | Medicinal compounds | |
| GB0204719D0 (en) | Medicinal compounds | |
| GB0225535D0 (en) | Medicinal compounds | |
| GB0220730D0 (en) | Medicinal compounds | |
| GB0225030D0 (en) | Medicinal compounds | |
| GB0303396D0 (en) | Medicinal compounds | |
| GB0308511D0 (en) | Pharmaceutical compounds | |
| GB0328490D0 (en) | Medicinal compounds | |
| GB0317315D0 (en) | Pharmaceutical compounds | |
| EP1484061A4 (en) | Drugs containing riboflavin-type compounds | |
| GB0313766D0 (en) | Pharmaceutical compounds | |
| GB2401043B (en) | Drug | |
| GB0301736D0 (en) | Pharmaceutical compounds | |
| EP1669087A4 (en) | Preparation containing basic drug | |
| GB0329617D0 (en) | Pharmaceutical compounds | |
| EP1624073A4 (en) | Drug | |
| GB0324889D0 (en) | Medicinal compounds | |
| GB0328491D0 (en) | Medicinal compounds | |
| GB0312509D0 (en) | Pharmaceutical compounds | |
| GB0329611D0 (en) | Pharmaceutical compounds | |
| GB0324919D0 (en) | Pharmaceutical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |